Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact
Eli Lilly is joining forces with artificial intelligence (AI)-powered biotech, Insilico Medicine, in a drug discovery and development…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
FDA approves high-dose Wegovy shots
Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help…
2 Top AI Healthcare Stocks to Buy and Hold
Many of the top companies successfully cashing in on artificial intelligence (AI) are in the technology sector. However,…
Eli Lilly on track to launch oral obesity drug in second quarter, pending US approval
March 2 (Reuters) – Eli Lilly CFO ‌Lucas Montarce said ‌on Monday it is ​preparing to launch its…
The Best Healthcare Stock to Invest $1,000 in Right Now
When you think “top-performing pharma stock,” Eli Lilly may first come to mind. Yet while Lilly’s shares have…
1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market Crash
Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs.…
Why haven’t Trump’s tariffs caused a downturn in the US? – The Irish Times
When Donald Trump famously announced his Liberation Day tariff assault on the world last April, economists, almost en…
NHS must keep medicine rebate down or lose investment
Wednesday 18 February 2026 2:27 pm  |  Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
JPMorgan builds $2.93 billion stake in health care stock
JPMorgan Chase just planted a massive $2.93 billion flag in perhaps one of the hottest corners of the…
This Pharma Giant Is Using AI to Dominate Drug Discovery
There’s no denying modern-day artificial intelligence (AI) is doing some pretty cool stuff. But, to say it’s been…
What’s the Better Long-Term Investment?
Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are rivals in the GLP-1 drug market and are…